Literature DB >> 9694804

PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

C Nerlov1, T Graf.   

Abstract

Little is known about the transcription factors that mediate lineage commitment of multipotent hematopoietic precursors. One candidate is the Ets family transcription factor PU.1, which is expressed in myeloid and B cells and is required for the development of both these lineages. We show here that the factor specifically instructs transformed multipotent hematopoietic progenitors to differentiate along the myeloid lineage. This involves not only the up-regulation of myeloid-specific cell surface antigens and the acquisition of myeloid growth-factor dependence but also the down-regulation of progenitor/thrombocyte-specific cell-surface markers and GATA-1. Both effects require an intact PU.1 transactivation domain. Whereas sustained activation of an inducible form of the factor leads to myeloid lineage commitment, short-term activation leads to the formation of immature eosinophils, indicating the existence of a bilineage intermediate. Our results suggest that PU.1 induces myeloid lineage commitment by the suppression of a master regulator of nonmyeloid genes (such as GATA-1) and the concomitant activation of multiple myeloid genes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9694804      PMCID: PMC317050          DOI: 10.1101/gad.12.15.2403

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  41 in total

1.  A functional Ets DNA-binding domain is required to maintain multipotency of hematopoietic progenitors transformed by Myb-Ets.

Authors:  N Kraut; J Frampton; K M McNagny; T Graf
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

2.  Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.

Authors:  M H Baron; S M Farrington
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

Review 3.  Vintage reds and whites: combinatorial transcription factor utilization in hematopoietic differentiation.

Authors:  S A Ness; J D Engel
Journal:  Curr Opin Genet Dev       Date:  1994-10       Impact factor: 5.578

4.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages.

Authors:  E W Scott; M C Simon; J Anastasi; H Singh
Journal:  Science       Date:  1994-09-09       Impact factor: 47.728

5.  Cell surface proteins of chicken hematopoietic progenitors, thrombocytes and eosinophils detected by novel monoclonal antibodies.

Authors:  K M McNagny; F Lim; S Grieser; T Graf
Journal:  Leukemia       Date:  1992-10       Impact factor: 11.528

6.  PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer.

Authors:  G Henkel; M A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-02       Impact factor: 11.205

7.  The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro.

Authors:  C Hagemeier; A Cook; T Kouzarides
Journal:  Nucleic Acids Res       Date:  1993-11-11       Impact factor: 16.971

8.  Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.

Authors:  D Orlic; S Anderson; L G Biesecker; B P Sorrentino; D M Bodine
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Thrombomucin, a novel cell surface protein that defines thrombocytes and multipotent hematopoietic progenitors.

Authors:  K M McNagny; I Pettersson; F Rossi; I Flamme; A Shevchenko; M Mann; T Graf
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

10.  Immortalization of multipotent growth-factor dependent hemopoietic progenitors from mice transgenic for GATA-1 driven SV40 tsA58 gene.

Authors:  L A Cairns; S Crotta; M Minuzzo; E Moroni; F Granucci; S Nicolis; R Schiró; L Pozzi; B Giglioni; P Ricciardi-Castagnoli
Journal:  EMBO J       Date:  1994-10-03       Impact factor: 11.598

View more
  147 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  BSAP can repress enhancer activity by targeting PU.1 function.

Authors:  S Maitra; M Atchison
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Mapping of complex regulatory elements by pufferfish/zebrafish transgenesis.

Authors:  E V Rothenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

4.  Inhibition of CBP-mediated protein acetylation by the Ets family oncoprotein PU.1.

Authors:  Wei Hong; Alexander Y Kim; Sokun Ky; Carrie Rakowski; Sang-Beom Seo; Debabrata Chakravarti; Michael Atchison; Gerd A Blobel
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

Review 5.  Plasticity and maintenance of hematopoietic stem cells during development.

Authors:  Suman Kanji; Vincent J Pompili; Hiranmoy Das
Journal:  Recent Pat Biotechnol       Date:  2011-04

6.  Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells.

Authors:  Clare Heyworth; Stella Pearson; Gillian May; Tariq Enver
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 7.  Transcriptional regulation of macrophage polarization: enabling diversity with identity.

Authors:  Toby Lawrence; Gioacchino Natoli
Journal:  Nat Rev Immunol       Date:  2011-10-25       Impact factor: 53.106

Review 8.  Transcriptional programming of the dendritic cell network.

Authors:  Gabrielle T Belz; Stephen L Nutt
Journal:  Nat Rev Immunol       Date:  2012-01-25       Impact factor: 53.106

Review 9.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

10.  EBF1-deficient bone marrow stroma elicits persistent changes in HSC potential.

Authors:  Marta Derecka; Josip Stefan Herman; Pierre Cauchy; Senthilkumar Ramamoorthy; Ekaterina Lupar; Dominic Grün; Rudolf Grosschedl
Journal:  Nat Immunol       Date:  2020-02-17       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.